Clinical Trials
- Brain, Spinal Cord & Nervous System
Evaluating the Immune Response to COVID-19 Vaccination in B-cell Depleted Patients
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System
Myasthenia Gravis Inebilizumab Trial (MINT)
- Ages18 years and older
- GenderBoth
- Alzheimer's
test
- Ages55 years - 80 years
- GenderBoth
- Diabetes
Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab (PROTECT)
- Ages8 years - 17 years
- GenderBoth
- Aging, Brain, Spinal Cord & Nervous System
Dementia Caregiving Qualitative Study
- Immune System
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis
- Mental Health & Behavioral Research, Alzheimer's
Ketamine for the Treatment of Depression in Parkinson's Disease
- Ages40 years - 70 years
- GenderBoth
- Brain, Spinal Cord & Nervous System
Imaging the Dopamine Transporter in Parkinson's Disease
- Ages40 years and older
- GenderBoth
- Immune System, Infectious Disease
Multicenter, Open Label, Phase 3 Trial of ATA129 for Solid Organ Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE Study)
- GenderBoth
- Alzheimer's
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. (DIAN-TU)
- Ages18 years - 80 years
- GenderBoth